WILMINGTON, Del. — Kurt M. Landgraf has been elected chief financial officer of DuPont.
Landgraf, 50, currently president and chief executive officer of DuPont Merck Pharmaceutical Co., a joint venture of DuPont and Merck & Co.., will assume his new role Dec. 1. He will oversee DuPont’s finance, sourcing and corporate planning and will become a member of the office of the chief executive officer. He also will become co-chair of the board of DuPont Merck.
Landgraf succeeds Charles L. Henry, who retired from DuPont in September to become chairman, president and chief executive officer of Schuller Corp.

load comments
blog comments powered by Disqus